Taiwan · Delayed Price · Currency is TWD Adimmune Statistics
Total Valuation
Adimmune has a market cap or net worth of TWD 7.29 billion. The enterprise value is 8.46 billion.
| Market Cap | 7.29B |
| Enterprise Value | 8.46B |
Important Dates
The next estimated earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Adimmune has 421.51 million shares outstanding.
| Current Share Class | 421.51M |
| Shares Outstanding | 421.51M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.45% |
| Owned by Institutions (%) | 2.43% |
| Float | 313.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.32 |
| PB Ratio | 1.55 |
| P/TBV Ratio | 1.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.47, with a Debt / Equity ratio of 0.62.
| Current Ratio | 4.47 |
| Quick Ratio | 2.73 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | n/a |
| Debt / FCF | -12.33 |
| Interest Coverage | -7.74 |
Financial Efficiency
Return on equity (ROE) is -4.40% and return on invested capital (ROIC) is -5.15%.
| Return on Equity (ROE) | -4.40% |
| Return on Assets (ROA) | -1.98% |
| Return on Invested Capital (ROIC) | -5.15% |
| Return on Capital Employed (ROCE) | -3.51% |
| Weighted Average Cost of Capital (WACC) | 4.29% |
| Revenue Per Employee | 2.43M |
| Profits Per Employee | -254,638 |
| Employee Count | 564 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 1.08 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.86% in the last 52 weeks. The beta is 0.25, so Adimmune's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -0.86% |
| 50-Day Moving Average | 17.27 |
| 200-Day Moving Average | 18.32 |
| Relative Strength Index (RSI) | 52.64 |
| Average Volume (20 Days) | 1,148,735 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Adimmune had revenue of TWD 1.37 billion and -143.62 million in losses. Loss per share was -0.34.
| Revenue | 1.37B |
| Gross Profit | 316.48M |
| Operating Income | -259.86M |
| Pretax Income | -211.21M |
| Net Income | -143.62M |
| EBITDA | -66.83M |
| EBIT | -259.86M |
| Loss Per Share | -0.34 |
Balance Sheet
The company has 1.82 billion in cash and 2.91 billion in debt, with a net cash position of -1.09 billion or -2.58 per share.
| Cash & Cash Equivalents | 1.82B |
| Total Debt | 2.91B |
| Net Cash | -1.09B |
| Net Cash Per Share | -2.58 |
| Equity (Book Value) | 4.70B |
| Book Value Per Share | 10.97 |
| Working Capital | 2.49B |
Cash Flow
In the last 12 months, operating cash flow was -31.34 million and capital expenditures -204.93 million, giving a free cash flow of -236.28 million.
| Operating Cash Flow | -31.34M |
| Capital Expenditures | -204.93M |
| Depreciation & Amortization | 177.68M |
| Net Borrowing | -8.56M |
| Free Cash Flow | -236.28M |
| FCF Per Share | -0.56 |
Margins
Gross margin is 23.10%, with operating and profit margins of -18.97% and -10.48%.
| Gross Margin | 23.10% |
| Operating Margin | -18.97% |
| Pretax Margin | -15.42% |
| Profit Margin | -10.48% |
| EBITDA Margin | -4.88% |
| EBIT Margin | -18.97% |
| FCF Margin | n/a |
Dividends & Yields
Adimmune does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -1.97% |
| FCF Yield | -3.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |